PRGO Stock Analysis: Buy, Sell, or Hold?

PRGO - PERRIGO COMPANY PLC

PHARMACEUTICAL PREPARATIONS
$10.83
-0.18 (-1.59%) ▼
5d: +15.41%
30d: -7.4%
90d: -22.23%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Accumulation

PRGO is down 4.9% this week, but smart money is accumulating calls. Top strike: $12.5 2026-05-15 with 1,065 OI. Call ratio: 71% View Scanner →

Strength: 4.6/10

Get Alerted When PRGO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: PRGO shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$17.78
Based on 8.7% avg growth
INTRINSIC VALUE TODAY
$11.04
2.0% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 4.9x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: PRGO is currently trading at $10.82, which is considered fair relative to its 30-day fair value range of $9.21 to $12.60. The stock's valuation (Forward PE: 4.6) is in line with its historical norms (4.9). Remarkably, the market is currently pricing in an annual earnings decline of 2.3% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, PRGO is in a downtrend. Immediate support is located at $9.22, while resistance sits at $11.32.

Market Sentiment: PRGO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.00 (+54.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Fair Price Range $9.21 - $12.60
Company Quality Score 58/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 83.3%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 54.5% below Wall St target ($17.00)

Fair Price Analysis

30-Day Fair Range $9.21 - $12.60
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $9.23
Resistance Level $11.32
Current Trend Downtrend
Technical data as of Apr 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) 4.59
Wall Street Target $17.00 (+54.5%)
Revenue Growth (YoY) -2.5%
Earnings Growth (YoY) -63.6%
Profit Margin -33.5%
Valuation Discount vs History -2.3% cheaper
PE vs Historical 4.6 vs 4.9 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -2.3% (market-implied from PE analysis)
1-Year Target $10.75 (-2%)
2-Year Target $10.50 (-5%)
3-Year Target $10.26 (-7%)
3-Yr Target (if PE normalizes) (PE: 5→5) $10.95 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.4, Growth: 13.4%) $78.05 (+610%)
Base: (SPY PE: 4.6, Growth: 13.4%) $16.03 (+46%)
Bear: (PE: 3.9, Growth: 13.4%) $13.62 (+24%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 4.6 to 4.9
Stabilization Target: $11.75 (+6.8%)
PE Expansion Potential: +6.8%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: April 02, 2026 3:25 PM ET
Data refreshes hourly during market hours. Next update: 4:25 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Geoffrey M Parker BUY 7500 shares 2025-11-12

Unlock Insider Activity

See real-time buying/selling by company executives for PRGO.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
25 analysts
$178 63 BUY
ZTS
Zoetis Inc
STRONG BUY
19 analysts
$151 63 BUY
LNTH
Lantheus Holdings Inc
STRONG BUY
13 analysts
$91 61 BUY
BCRX
BioCryst Pharmaceuticals…
STRONG BUY
12 analysts
$21 55 HOLD
HCM
HUTCHMED DRC
STRONG BUY
14 analysts
$21 56 HOLD

Advanced PRGO Option Strategies

Professional options setups generated by AI based on today's PRGO price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for PRGO

PRGO Technical Chart PRGO Price Prediction PRGO Earnings Date PRGO Investment Advisor PRGO Fair Price Analyzer PRGO Options Advisor PRGO Options Chain PRGO Options Analysis PRGO Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals